Overview

Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer

Status:
RECRUITING
Trial end date:
2028-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of chemotherapy plus radiotherapy to patients with CA19-9-elevated Advanced Pancreatic Cancer who are not refractory to chemotherapy.
Phase:
PHASE3
Details
Lead Sponsor:
Fudan University
Treatments:
130-nm albumin-bound paclitaxel
Gemcitabine
Irinotecan
Radiotherapy, Intensity-Modulated